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Abstract
Wound healing involves several steps: spreading of the cells, migration and prolifer-
ation. We have proﬁled gene expression during the early events of wound healing in
normal human keratinocytes with a home-made DNA microarray containing about
1000 relevant human probes. An original wounding machine was used, that allows the
wounding of up to 40% of the surface of a conﬂuent monolayer of cultured cells grown
on a Petri dish (compared with 5% with a classical ‘scratch’ method). The two aims
of the present study were: (a) to validate a limited number of genes by comparing
the expression levels obtained with this technique with those found in the literature;
(b) to combine the use of the wounding machine with DNA microarray analysis for
large-scale detection of the molecular events triggered during the early stages of the
wound-healing process. The time-courses of RNA expression observed at 0.5, 1.5, 3,
6 and 15 h after wounding for genes such as c-Fos, c-Jun, Egr1, the plasminogen
activator PLAU (uPA) and the signal transducer and transcription activator STAT3,
were consistent with previously published data. This suggests that our methodologies
are able to perform quantitative measurement of gene expression. Transcripts encod-
ing two zinc ﬁnger proteins, ZFP36 and ZNF161, and the tumour necrosis factor
α-induced protein TNFAIP3, were also overexpressed after wounding. The role of
the p38 mitogen-activated protein kinase (p38MAPK) in wound healing was shown
after the inhibition of p38 by SB203580, but our results also suggest the existence of
surrogate activating pathways. Copyright  2003 John Wiley & Sons, Ltd.
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Introduction
After an epithelial injury, wound healing results
from a combination of cell growth, proliferation,
migration and differentiation, all of these processes
being associated with altered expression of spe-
ciﬁc genes. Although some of these genes are
already known, the speciﬁc pathways involved
in the transduction of the healing signals remain
largely to be deﬁned. In mammals, three distinct
mitogen-activated protein kinase (MAPK) cascades
have been identiﬁed: (a) the c-Jun-N-terminal pro-
tein kinase (JNK) cascade; (b) the p38 MAP
kinase (p38MAPK) cascade; and (c) the extracel-
lular signal-regulated kinase (ERK) cascade. They
are known to be involved in the transduction of
stress- or injury-induced signals (Jaakkola et al.,
1998; Turchi et al., 2002). The activation of MAP
kinases has been observed after wounding in cul-
tured cells (Dieckgraefe et al., 1997; Goke et al.,
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1998) and entire tissues (Seo et al., 1995; Aronson
et al., 1998). The ERK cascade also plays an
important role in mediating cell proliferation in
response to growth factors. ERK displays a bipha-
sic activation with two peaks, at 10 min and after
2 h (Meloche et al., 1992). The ﬁrst peak coincides
with the monophasic p38 activation (Lee et al.,
2000). C-fos,t h ee arly growth response factor Egr1
(or Krox-24), and other immediate early genes, are
activated after a wound (Grembowicz et al., 1999;
Martin and Nobes, 1992; Grose et al., 2002; Verrier
et al., 1986). Because many of these genes encode
transcription factors, they are able to transactivate
multiple selected secondary targets.
In order to identify new immediate early genes,
we have used a spiral scariﬁcator, that develops a
large wound over the surface of a conﬂuent mono-
layer of cultured cells (Turchi et al., 2002). The
two aims of the present study were: (a) to validate
a limited number of genes (about 1000 probes) by
comparing the expression levels obtained with this
technique with those found in the literature; (b) to
combine the use of the wounding machine with
DNA microarray analysis, in order to detect on a
large scale the molecular events triggered during
the early stages of the wound-healing process under
controlled conditions.
Materials and methods
Probe design and microarray printing
The cDNA probes were produced by PCR ampli-
ﬁcation. The probes were selected from 13440
RefSeq sequences (i.e. conﬁrmed human tran-
scripts), using an automated BLAST parsing pro-
gram. All probes (i) had a normalized length of
250 bp ± 19 bp; (ii) had a normalized GC con-
tent of 52% ± 8%; and (iii) were speciﬁc for a
unique human gene. Probes were selected among
ion or solute transport proteins, cytokines and other
inﬂammatory molecules, growth factors, metallo-
proteases, transcription factors, protein kinases and
signal transduction molecules. The ﬁnal list of the
probes spotted on the microarray is available on
http://medlab.ipmc.cnrs.fr/Gene List.html.W e
puriﬁed our PCR products using 96-well mul-
tiscreen ﬁlter plates (MAFNOB 50, Millipore).
The arrays were printed on aldehyde-coated glass
microscope slides using a robot (SDDC-2, Virtek
arrayer). Microarrays were prepared by print-
ing in duplicate PCR amplicons resuspended in
3×SSC, with an average spotting concentration of
200 ng/µl.
Target preparation and hybridization
Keratinocyte primary cultures and wound healing
Human keratinocytes were isolated from healthy
neonatal foreskin and grown as conﬂuent mono-
layers in 100 mm culture dishes as described by
Rheinwald and Green (1975).
The wounding was performed using a spiral
scariﬁcator, previously described by Turchi et al.
The cultures were stopped by washing with phos-
phate buffer saline, followed by a quick freezing to
−80 ◦C, at different times after wounding (30 min,
1 h 30 s, 3 h, 6 h and 15 h). For each time of the
kinetic series, non-wounded cells were used as con-
trols. In experiments performed with the p38MAPK
inhibitor, 30 µM SB203580 were preincubated with
the cells 2 h before wounding.
RNA extraction
Cells (5–10 x × 106) were quickly homogenized in
10 ml 4 M guanidium thiocyanate solution, 25 mM
sodium citrate, pH 7.0, 100 mM β-mercaptoethanol,
0.5% N-laurylsarcosine, followed by the addition
of 1 ml 2 M sodium acetate, pH 4.0, 8 ml freshly
water-equilibrated phenol, and 2 ml chloroform.
After 15 min on ice, the samples were centrifuged
for 20 min at 7500 × g. The RNA of the upper
aqueous phase was precipitated with one volume
of isopropanol. The sample was incubated for 1 h
on ice, after which the RNA was pelleted by cen-
trifugation for 20 min at 7500 × g. The pellet was
washed twice with 70% ethanol, then resuspended
in RNase-free water.
Cy3- and Cy5-labelled cDNA
The CyDye-labelled ﬁrst-strand cDNAs were
generated with the CyScribe First-Strand cDNA
Labelling Kit (RPN 6200, Amersham Pharmacia
Biotech). We used Cy3-dCTP and Cy5-dCTP
(Amersham Pharmacia Biotech) for a direct
labelling. Total RNA (5–10 µg) was used
as template. Unincorporated CyDye-nucleotides
were removed using the Nucleotide Removal
Kit (Qiagen).
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Post-processing
All washes were performed at room temperature,
except when noted, with vigorous agitation. Printed
arrays were post-processed by washing twice in
0.2% SDS for 2 min, then twice for 2 min in
distilled water, followed by 2 min in 95–100 ◦C
distilled water. Arrays were then treated for 5 min
i naN a B H 4 solution (0.5 g NaBH4 in 150 ml PBS
and 45 ml ethanol). The arrays were rinsed three
times in 0.2% SDS for 2 min, followed by two
washes in distilled water for 1 min. The arrays
were then immersed for 30 min in a blocking
solution (0.5 g casein, 250 ml PBS, 200 µl Tween
20; I-block, Tropix, Bedford, MA) and ﬁnally
washed for 2 min in 0.2% SDS, three times for
1 min in distilled water, spun dry, then stored
under vacuum.
Hybridization
The microarray was covered with 20 µl hybridiza-
tion buffer (DigEasy Roche) containing the Cy3/5-
labelled samples, and was overlain with a glass
cover slip (Erie Scientiﬁc, Portsmouth, USA). The
hybridization was performed overnight at 48 ◦C.
Arrays were washed for 5 min in 1×SSC–0.03%
SDS, 5 min in 0.2×S S C ,5 m i ni n0 . 0 5 ×SSC,
1 min in H2O, 1 min in isopropanol, then spun dry.
Data collection and analysis
Data collection
Arrays were scanned using a confocal gas-laser
scanner (ScanArray 5000, GSI Lumonics), and the
ScanArray program (LEAD Technologies Imaging
Products). The two red and green lasers operated
at 633 nm and 543 nm to excite Cy5 and Cy3,
respectively. The intensity was measured at 670 nm
for Cy5 and 570 nm for Cy3. The two 16-bit
Tiff images containing the data from each ﬂuores-
cence channel were analysed by the QuantArray
(2.0.0.0a) program.
Centralization
Cy3 and Cy5 dyes differ in their respective incorpo-
rations into cDNA (related to their relative afﬁni-
ties for the reverse transcriptase) and their quan-
tum yields. This leads to signiﬁcant differences
in emissions. In order to eliminate dye-dependent
differences, a ‘dye-swap’ protocol was used: in
a ﬁrst microarray, cDNAs derived from wounded
and control cells were labelled with Cy3 and
Cy5, respectively; in a second ‘swap’ microarray,
cDNAs derived from wounded and control cells
were labelled with Cy5 and Cy3, respectively (Kerr
and Churchill, 2001). If Cy3(genei)[wounded] rep-
resents the ﬂuorescence intensity for genei in the
ﬁrst slide, and Cy5(genei)[wounded]swap represents
the ﬂuorescence intensity for the same genei in the
swapped slide, the speciﬁc signal associated with
genei in RNA derived from wounded cells (called
wounded[genei]) is deﬁned as the geometrical aver-
age of the speciﬁc intensities in Cy3 and Cy5:
wounded[genei] =

Cy3(genei)[wounded]×

Cy5(genei)[wounded]swap
This value is independent of cyanine incorporation
(not shown).
Experimental design
Each time point was independently analysed three
times. The keratinocytes used for these three inde-
pendent time-courses were derived from the same
primary culture. Taken together with the two arrays
(one array and its swap) hybridized for each exper-
imental condition, data for each time point in
the present study were derived from a total of
six arrays.
In order to ascertain the quality of hybridiza-
tion, each array contained 192 internal control spots
corresponding to ‘spike’ control probes. These con-
trol DNA probes were spotted at concentrations
ranging from 0 to 200 ng/µl and correspond to
invertebrate sequences that do not cross-react with
any known mammalian genes (corresponding to
GenBank Accession Nos X92113, Y16225, and
Y16240). Corresponding RNAs were produced by
in vitro transcription, and the experimental RNAs
were reverse-transcribed in the presence of differ-
ent amounts of the three different ‘spike’ RNAs.
These different amounts of spike RNA resulted
in ratios of 1:1, 1:0 and 0:1 that were com-
pared with the experimental values deduced from
the ﬂuorescence measurements. The correspond-
ing spots were used to check the consistency of
the results. Only experiments showing consistent
red, yellow and green spots for ratios of 1:0,
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1:1 and 0:1, respectively, were kept for subse-
quent analysis. The ﬁnal results were expressed as
the averages of the ratios between the intensities
of ‘wounded cells’ over the intensities of ‘non-
wounded’ cells.
Results and discussion
In vitro wound healing has been extensively studied
after a mechanical injury using a scalpel on con-
ﬂuent monolayers of cultured cells (scratch tech-
nique). Until now, the pitfalls of this approach
have been a percentage of injured cells too low
for quantitative measurements, and the difﬁculty of
obtaining a perfectly reproducible wound. We used
a spiral scariﬁcator (Turchi et al., 2002), which
allows the wounding of a larger number of cells
(30–40%) compared to the classical scratching
methods (5%). Moreover, the wounding was per-
fectly automated and reproducible. After wound-
ing, total RNAs were extracted at different times,
and analysed on a DNA microarray. We used
for our study ‘laboratory-made’ arrays contain-
ing 1000 genes corresponding to conﬁrmed human
transcripts. In order to distinguish truly expressed
genes from stochastic ﬂuctuations, the averages of
three independent assays were combined. The rel-
ative expression of each gene was expressed as
the average of the ratios of the normalized mea-
sured intensity for wounded cells vs. the inten-
sity measured for control ‘non-wounded’ cells. For
closely related samples, such as in our wounded vs.
non-wounded experiments, gene expression should
remain globally unaffected between the two con-
ditions (Whiteley et al., 2001). Accordingly, the
different distributions of the ratios were centred
around 1, over the entire time-course of the exper-
iment (Figure 1). In an initial attempt to check the
prediction power of the microarray technique in
this model, we focused our attention on the genes
displaying the largest variations. Depending on the
slides, genes with ratios above 1.7–2.5 or below
0.4–0.6 were subsequently analysed.
Table 1 shows the list of genes that were mod-
ulated in keratinocytes after injury. Interestingly,
the chromosomal localization of EGR1 on chro-
mosome 5q, of CTGF on chromosome 6q and
of DMTF1 on chromosome 7q were close to the
chromosomal localizations of TCF7, TNFAIP3 and
0
0 0.4 0.8 1.2
intensity ratio
1.6 2 2.4 2.8
50
100
150
200
f
r
e
q
u
e
n
c
y
250
300
30 min
1h 30 min
3 h
6 h
15 h
Figure 1. Distribution of the intensity ratios for each
time experiment. The frequency of each intensity ratio
was expressed for each time experiment (30 min, 1 h 30 s,
3 h, 6 h and 15 h). Each time corresponds to an array.
Intensity ratios represent the ratio between the intensities
measured for wounded cells vs. the intensities measured
for non-wounded cells. For each array, the observed ratios
are distributed around one
SERPINE1, respectively, and the pairs of tran-
scripts exhibited parallel changes in expression.
These results could be explained by the proposal
that enhancers, locus control regions and silencers
can alter the expression of multiple genes within
regions of the genome (Lee and Young, 2000).
The MAPK pathways have been established as
the major signalling modules through which cells
transduce extracellular signals. Immediate early
transcription genes, such as c-Fos, c-Jun and
Egr1, are targets for induction and/or activation by
MAPK and could mediate the nuclear response to
the injury stimulus. Fos induction in response to
injury has been described in a broad range of tis-
sues and may be an indicator of early MAPK path-
way activation. Indeed, Figure 2A shows a tran-
sient 14-fold induction of c-Fos mRNA 30 min
after wounding, that decreases rapidly by more
than 90% after 1 h. The quantity of Egr1 mRNA
also increased more than a factor of four, with a
similar time-course (Figure 2A). In contrast, the
expression of c-Jun mRNA was stimulated rapidly
after injury (Figure 2A) but its stimulation was
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Table 1. Classiﬁcation of genes involved in the response to wounding
Wounded/control
Chromosomal
position Symbol Locus link [min–max]0 [min–max]SB Class
1p32-p31 JUN 3725 0.98–1.84 0.72–1.84 A
1p34.3 MACMARCKS 65108 0.51–1.1 0.69–1.76 B
1p36 EPHA2 1969 0.71–1.75 0.68–1.92 C
1p36.2 SLC2A5 6518 0.34–1.63 0.62–1.76 B
1q21 MCL1 4170 0.83–2.10 0.75–2.43 D
1q22-q23 CD1D 912 0.77–1.68 0.69–3.14 C
1q32.2 ELF3 1999 0.57–1.46 0.58–1.81 A
1q42-q43 KCNK1 3775 0.53–1.70 0.72–1.67 B
2p22-p21 LTBP1 4052 0.55–1.26 0.59–1.65 E
2q11-q14 SLC20A1 6574 0.72–1.84 0.67–1.58 B
2q14 IL1A 3552 0.72–1.60 0.41–1.70 E
2q33-q34 CASP8 841 0.87–1.78 0.65–2.00 D
2q37 ATSV 547 0.91–2.95 1.14–4.00 F
3q28-q29 CLDN1 9076 0.78–1.59 1.40–6.16 C
4q13-q21 IL8 3576 0.83–1.77 0.71–3.58 E
5q13.1 OCLN 4950 0.57–1.39 0.75–2.17 C
5q31.1 EGR1 1958 0.58–4.47 0.25–1.67 A
5q31.1 TCF7 6932 0.42–1.23 0.68–2.04 A
6p24.1 EDN1 1906 0.83–1.32 0.69–2.33 E
6q23.1 CTGF 1490 0.80–1.64 0.65–1.82 E
6q23.1-q25.3 TNFAIP3 7128 0.67–4.63 0.74–2.46 A
7q21 DMTF1 9988 0.88–2.17 0.66–3.60 A
7q21.3-q22 SERPINE1 5054 0.79–1.51 0.47–3.26 G
8q21.2 E2F5 1875 0.36–1.20 0.52–1.83 A
8q22.2 TIEG 7071 0.34–1.13 0.88–2.80 A
10q24 PLAU 5328 0.82–2.36 1.00–3.17 G
11q23 CD3D 915 0.53–1.19 0.57–2.02 C
14q24.3 FOS 2353 0.72–13.56 0.56–1.40 A
17q11.2-q12 SCYA5 6352 0.63–2.14 0.73–2.19 E
17q23.2 ZNF161 7716 0.64–2.83 0.52–1.89 A
18q21.3 SERPINB2 5055 1.23–3.70 1.28–13.76 G
19q13.1 ZFP36 7538 0.71–3.31 0.69–2.67 A
20 TCEA2 6919 0.54–2.07 0.58–2.01 H
20p12-p11.2 SNAP25 6616 0.61–1.17 0.68–2.12 B
22q13.1 HMOX1 3162 0.65–2.06 0.78–1.95 B
Xp22.3 IL3RA 3563 0.32–1.80 0.50–1.83 C
Unknown FGF16 8823 0.55–1.09 0.55–3.00 E
Symbols: JUN, v-jun oncogene; MACMARCKS, macrophage myristoylated alanine –rich C kinase substrate; SLC2A5, solute carrier
family 2, member 5; MCL1, myeloid cell leukemia sequence 1; CDID,C D I Da n t i g e n ;ELF3, E74-like factor 3 (ets-domain transcription
factor, epithelial-speciﬁc); KCNK1, potassium channel, subfamily K, member 1; LTBP1, latent transforming growth factor β binding protein 1;
SLC20A1, solute carrier family 20, member 1; IL1A, interleukin 1 α; CASP8, caspase 8, apoptosis-related cysteine protease; ATSV,a x o n a l
transport of synaptic vesicles; CLDN1, claudin 1; IL8, interleukin 8; OCLN occludin; EGR1, early growth response 1; TCF7, transcription
factor 7; EDN1, endothelin 1; CTGF connective tissue growth factor; TNFAIL3, tumour necrosis factor, α-induced protein 3; DMTF1,
cyclin D binding myb-like transcription factor 1; SERPINE1, serine (or cysteine) proteinase inhibitor, clade E; E2F5, E2F transcription factor
5; TIEG, TGFβ-inducible early growth response; PLAU, plasminogen activator, urokinase; CD3D,C D 3 Da n t i g e n ;FOS, v-fos oncogene;
SCYA5, small inducible cytokine A5 (RANTES); ZNF161, zinc ﬁnger protein 161; SERPINB2, serine (or cysteine) proteinase inhibitor,
clade B; ZFP36, zinc ﬁnger protein 36; TCEA2, transcription elongation factor A, 2; SNAP25, stnaptosomal-associated protein; HMOX1,
heme oxygenase (decycling) 1; IL3RA, interleukin 3 receptor, α; FGF16: ﬁbroblast growth factor 16.
[min–max]0, minimum and maximum average ratios obtained for wounded keratinocytes in the absence of SB203580;[min-max]SB, minimum
and maximum average ratios obtained for wounded keratinocytes in the presence of SB203580. Ratios correspond to the normalized intensities
of wounded cells vs. control non-wounded cells. For each time point, the value is an average of three independent measurements. The
minimum (respectively the maximum) represents the minimal (respectively the maximum) average ratio observed over time (the different
time points being 0.5H, 1.5H, 3H, 6H and 15H).
Class:A, transcription factor; B, intracellular modulators/ion channels/signal transducers; C, receptors/cell surface proteins; D, cell cycle regula-
tors; E,growthfactors andcytokines; F,cytoskeletal components; G, proteases/protease inhibitors;H,DNASynthesis/modiﬁcation/transcription
and nucleotide metabolism. The entire data set is available at: http://medlab.ipmc.cnrs.fr/publications/Dayem2002 Comparative&
Functional Genomics
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Figure 2. Time series of the transcriptional expression of c-fos, c-jun, Egr1, PLAU, TNFAIP3, Zfp36 and ZNF161 in wounded
human keratinocytes, in the presence or absence of SB203580. Human keratinocytes grown as conﬂuent monolayers were
wounded using a spiral scariﬁcator. At different times (30 min, 1 h 30 s, 3 h, 6 h, 15 h) after wounding, total RNA was
extracted, reverse transcribed in the presence of a ﬂuorophore, and the labelled cDNAs were hybridized on a DNA
microarray. Intensity ratios correspond to the normalized ﬂuorescence intensities measured in wounded (W) vs. control
non-wounded (NW) keratinocytes. For the experiments performed in the presence of the p38 inhibitor SB203580, cells
were preincubated in 30 µM SB203580 2 h before wounding
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not transient and lasted for at least an additional
4 h, in total accordance with results published by
Turchi et al.
Mechanical damage created by injury leads to
the activation of stress kinases such as p38 and
JNK. To examine the role of p38MAPK on gene
expression after injury, cells were wounded in
the presence of a 30 µM concentration of a p38-
speciﬁc, cell-permeable inhibitor SB203580 (Lee
et al., 1994). The IC50 of p38 MAPK inhibition by
SB203580 in vitro is approximately 0.6 µM (Lee
et al., 1994): a 30 µM concentration of SB203580
therefore totally inhibits the enzyme. In the pres-
ence of the inhibitor, the wound-healing pro-
cess was delayed (data not shown) and several
genes were inhibited, including c-Fos, Egr1 and
c-Jun, known to be controlled by the p38 path-
way (Figure 2B). This selective inhibition proves
the validity of our microarray data analysis.
Because these initial results were consistent with
previous observations by Turchi et al., we then
analysed the effect of SB203580 on the expres-
sion pattern of other altered genes, which might
also be involved into the wound-healing pro-
cess. Among the other altered genes, we iden-
tiﬁed many genes either directly controlled by
Egr1, or displaying zinc-ﬁnger domains like Egr1.
Many genes suspected to be relevant for tissue
repair contain nucleotide recognition elements for
Egr1, such as the transforming growth factor-
β1( T G F β1; Kim et al., 1994; Dey et al., 1994),
the urokinase-type plasminogen activator PLAU
(uPA; Verde et al., 1988), the intercellular adhesion
molecule-1 (ICAM-1; Maltzman et al., 1996) and
the platelet-derived growth factor (PDGF; Khachi-
gian et al., 1996; Silverman et al., 1997). PLAU
possibly participates in wound repair, cell adhe-
sion and cell growth. Gene inactivation experi-
ments demonstrated that the wound-healing process
was markedly inhibited in PLAU-/- mice (Romer
et al., 1996). Our results show that PLAU expres-
sion was increased 2.5-fold 3 h after the wound and
was further stimulated by SB203580 (Figure 2C),
indicating that p38 is not directly involved in the
control of PLAU expression. Interestingly, other
experiments showed that the inhibition of p38
by SB203580 strongly potentiated the activity of
ERK1/2 stimulated by injury (data not shown). We
conclude from these experiments that, in response
to injury, the p38 cascade antagonizes the ERK
pathways. The higher level of expression of PLAU
in SB203580-treated cells (3.5-fold vs. 2.5-fold at
3 h) is therefore consistent with the potentiation of
ERK activity.
Like Egr1, TNFAIP3 (also known as ZFP-A20),
the tumour necrosis factor alpha-induced protein 3,
has zinc ﬁnger domains. TNFAIP3 was upregulated
approximately ﬁve-fold 3 h after injury. More than
60% of the effect was damped in the presence of
SB203580 (Figure 2D), indicating that TNFAIP3
can be directly activated by p38MAPK. However,
a two-fold stimulation was still observed 3 h after
inhibition of p38, suggesting that other pathway(s)
was(were) involved in the control of TNFAIP3
expression in healing cells.
Two zinc ﬁnger proteins, ZFP36 and ZNF161,
were also rapidly induced by the wound (Figure 2E,
F). ZNF161 has been suspected to participate in
the cellular defence response, but not ZFP36. No
direct evidence has yet been provided for the role of
these two proteins in response to wounding. When
the p38 inhibitor was present, the early induction
was totally inhibited, and induction of these two
genes took place later (3 h after wounding). These
results indicate the role of the p38 cascade for the
early induction, but also suggest the existence of a
surrogate activating pathway.
The STAT factors (STAT1-6) are a family of
signal transducers and activators of transcription
(Takeda and Akira, 2000). We also showed that, in
wounded keratinocytes, only STAT3 was induced
two-fold 90 min after wounding (Figure 3). This
information was in total agreement with data indi-
cating that STAT3 inactivation altered skin remod-
elling (Sano et al., 1999).
When cells were treated with SB203580, STAT3
was totally repressed, indicating that p38 is invol-
ved in its induction. In contrast, STAT1, 4 and 6
were not stimulated by injury, but were induced 3 h
after wounding only in the presence of SB203580
(Figure 3). p38 therefore exerts a negative effect
on the pathway controlling the expression of STAT
1, 4 and 6 in wounded keratinocytes.
The data obtained in the present study vali-
date the complex experimental line that we had
to develop in order to analyse DNA microarrays.
The good correlation existing between microar-
ray results and reference transcripts (c-fos, c-jun,
PLAU, STAT3, EGR1) is a good indication that our
procedures for experimental design of the probes,
production of the PCR fragments, coating, printing
and post-processing of the microarrays, labelling,
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Figure 3. Involvement of the STAT factors in the transcriptional response to wounding, in the presence or absence of
SB203580. Conﬂuent human keratinocytes were wounded using a spiral scariﬁcator. In experiments performed in the
presence of the inhibitor of p38 MAPK, the cells were preincubated with 30 µM SB203580 2 h before wounding. At different
times (30 min, 1 h, 3 h, 6 h, 15 h) after wounding, total RNA was extracted, and hybridized on a DNA microarray. STAT1,
STAT3, STAT4 and STAT6 expression is represented as the ratios of the normalized ﬂuorescence intensities measured in
wounded (W) vs. control non-wounded (NW) keratinocytes
hybridizations and quantiﬁcation, are valid. From a
biological point of view, the experiments described
herein conﬁrm known patterns of gene expres-
sion during the early steps of wound healing, but
they also provide original information concerning
genes that had never been related to this process,
such as TNFAIP3, ZFP36 or ZNF161 (see also
Table 1). From similar time courses of expression
in the presence or absence of SB203580, close
and complementary roles during the early steps
of wound healing, or a close genomic association,
can probably be inferred for previously unrelated
genes.
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